A National Cross-Sectional Survey on Real-World Experiences of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Use in Adults with Migraine in Finland

A National Cross-Sectional Survey on Real-World Experiences of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Use in Adults with Migraine in Finland

Abstract Introduction Calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) were the first preventive migraine treatment group to target the underlying cause of migraine. This survey evaluated real-life experiences of adults with migraine in Finland before and after using their current...

Full description

Saved in:
Bibliographic Details
Main Authors: Caroline S. Casey, Mari Pölkki, Elisa K. Suvanen, Ilona Iso-Mustajärvi, Timo Purmonen, Essi J. Peltonen, Camilla K. Appel, Niraj J. Patel, Lill-Brith Von Arx
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-04-01
Series:Pain and Therapy
Subjects:
CGRP
Erenumab
Fremanezumab
Finland
Galcanezumab
Migraine
Online Access:https://doi.org/10.1007/s40122-025-00719-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40122-025-00719-5

Similar Items